Skip to main content

Table 5 Relative matrix effect of lovastatin

From: Stability indicating LC-MS/MS method for estimation of lovastatin in human plasma: application to a bioequivalence study

Plasma lot

LOQQC (0.122 ng/mL)

HQC (28.716 ng/mL

 

Mean calculated concentrationa (% CV)b

% bias

Mean calculated concentrationa (% CV)b

% bias

Lot-1

0.121 (1.2)

−0.82

28.799 (0.20)

0.29

Lot-2

0.122 (5.2)

0.00

28.632 (0.00)

−0.29

Lot-3

0.126 (4.5)

3.28

28.145 (1.80)

−1.99

Lot-4

0.118 (0.6)

−6.56

29.527 (0.70)

1.14

Lot-5c

0.114 (4.4)

−3.28

29.042 (0.80)

2.82

Lot-6d

0.121 (4.1)

−0.82

28.960 (0.40)

0.85

  1. aMean of duplicate observations at each concentration
  2. bCoefficient of variation
  3. cHemolyzed plasma
  4. dLipemic plasma